Institutional investors hold a majority ownership of BDX through the 85.86% of the outstanding shares that they control. This interest is also higher than at almost any other company in the Medical Specialties industry. Last, during the quarter ended December 2012, these large investors purchased a net $3.9 million shares.
| Other institutional | 46.80% |
| Mutual fund holders | 39.06% |
| Individual stakeholders | 0.78% |